Sanofi India has strongly refuted a recent report claiming the company has initiated the sale or licensing of its flagship insulin brand, Lantus ... could also be on the table if outright sale ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Sanofi's rivals in the insulin field are nipping at its heels – Lantus sales dipped 5 per cent in the first half of 2015, and analysts don't expect Toujeo to make up for its decline.

Welcome to the world of opioid prescribing, where government mandates based upon Morphine Milligram Equivalents (MMEs) are ...

Today's best UK deal for £500 will get you 576.25 EUR plus delivery. Check the table of travel money rates below to see more competitive deals than the high street/airport bureau de change.

Ultimately, LPL was able to convert about 60% of NPH advisors and fell short of its target of 70%. Though LPL was not required to fork out a contingent payment as part of the deal, we think that ...

The 2024-25 Premier League table is tight for European qualification as another season of chaos approaches its climax. MORE-Premier League 2024-25 schedule, how to watch live It seemed clear that ...

And for eliminated teams, we’re using our 2025-26 Depth Charts to project their offseason outlook. More details on injuries here: ...

Here below you have a complete description of its most interesting features and benefits so you can make the most of it. The majority of other information websites display prices of a single ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Both products combine a long acting insulin with a GLP-1 analogue – Xultopy brings together Tresiba and Victoza, while Soliqua (formerly known as LixiLan) combines Lantus with Adlyxin (Lxyumia ...